Concurrent Session 5B: Abstract Session - Towards Elimination: Driving Hepatitis C Treatment Forward
Tracks
​
| Friday, August 8, 2025 |
| 11:45 AM - 12:45 PM |
| Ballroom 2 |
Speaker
​
Welcome & Introduction
11:45 AM - 11:50 AMBiography
Mr Dylan Vella-Horne
Research Assistant
Burnet
Evaluating hepatitis C treatment engagement and completion among clients of a medically supervised injecting room in Melbourne, Australia
11:50 AM - 12:05 PMBiography
Dylan Vella-Horne is a Master of Public Health candidate with six years of experience at Melbourne's Medically Supervised Injecting Room (MSIR). He has worked extensively in community settings and is currently a research assistant at Burnet Institute, focusing on blood-borne viruses, injecting drug use, and harm reduction initiatives.
Dr Lakhbinder Singh Kang
General Practitioner
Der
Real Results: Derbarl Yerrigan Health Service’s Impact in Hepatitis C Eradication
12:05 PM - 12:20 PMBiography
Dr Lakhbinder Kang has been a doctor for 30 years and has specialised in Aboriginal Health for more than 14 years.
Aboriginal health helped him to open his heart, find meaning and purpose, as well as a sense of belonging.
Dr Kang is passionate about the holistic nature of being a General Practitioner.
He has special interests in chronic disease management, continuous quality improvement (CQI) and equity in healthcare.
He is dedicated in helping the next generation of doctors going forward and is committed to GP registrar supervision and final year Notre Dame student audits.
His cultural background is Punjabi Sikh and has strong connections with his ancestral farming lands in India. He is grounded by his patient wife Parwinder and 2 young adult sons.
Mr Cameron Taylor
Aboriginal Health Practitioner
Derbarl Yerrigan Health Service
Real Results: Derbarl Yerrigan Health Service’s Impact in Hepatitis C Eradication
12:05 PM - 12:20 PMBiography
I am a Noongar man born in Perth and have been an Aboriginal Health Practitioner for 12 years. I started my working journey in Northam which is a country town in the Wheatbelt, an 1 hour and 30mins drive east of Perth where I worked in the AMS for 5 years. Now I live in Perth and work for Derbarl Yerrigan Heath Service in the Sexual Health team.
Dr JISOO A Kwon
Lecturer
Kirby Institute
PROGRESS TOWARDS HCV ELIMINATION IN AUSTRALIA: THE IMPACT OF DAA THERAPY AND EMERGING CHALLENGES
12:20 PM - 12:35 PMBiography
Amy Kwon is a mathematician at the Kirby Institute, UNSW. Her research involves the development of mathematical models to understand the epidemiology of HCV and predict the impact and cost-effectiveness of interventions. She is responsible for providing the key HCV estimates for Australia's Annual Surveillance Report.
Mr Shane Tillakeratne
Phd Student / Ra
Unsw/ Kirby Institute
HCV RNA Testing and Treatment Uptake Patterns in New South Wales, Australia: A Contemporary Analysis of the Advanced DAA Era
12:35 PM - 12:40 PMBiography
Shane is a research associate at the Kirby Institute, Sydney, whose research examines hepatitis C-related morbidity and mortality. With a background in epidemiology, Shane aims to enhance understanding of HCV's impact, particularly in marginalized populations, and explore ways to improve treatment outcomes and public health strategies.
Ms. Siddhi Ganesh
Doctoral Candidate
University Of Southern California
Variations in the viral Hepatitis C prevalence and treatment status by material hardship among people who inject drugs in Los Angeles, California and Denver, Colorado, United States
12:40 PM - 12:45 PMBiography
Sid Ganesh is a doctoral candidate in Health Behavior Research at the University of Southern California in Los Angeles. Her research examines the role of structural vulnerability in the production and treatment of infectious diseases among people who inject drugs and patients diagnosed with injection drug use related infective endocarditis.
Chairperson
Cherie Bennett
Nursing Policy and Advocacy Lead
ASHM
Jason Grebely
Professor
The Kirby Institute, Unsw Sydney